US Teleradiology Market

ID: MRFR/HC/14848-HCR 100 Pages Rahul Gotadki Last Updated: September 17, 2026
US Teleradiology Market Research Report: Size, Share, Trend Analysis By Applications (Bone Imaging, Cardiac Imaging, Neuroimaging, Oncology Imaging, Chest Imaging), By Modality (X-Ray, CT Scan, MRI, Ultrasound, Nuclear Medicine), By End Use (Hospitals, Diagnostic Imaging Centers, Research Organizations, Home Healthcare, Emergency Care) and By Configuration (Cloud-Based, Web-Based, Standalone) - Growth Outlook & Industry Forecast 2025 To 2035
US Teleradiology Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.69%
2024 Market Size$ 1,177.55 Million
2035 Market Size$ 2,400 Million
Key Players
Radiology Partners
vRad
Teleradiology Solutions
Mednax
TeleRadiology
Nighthawk Radiology
Opportunities
  • Rising Healthcare Costs
  • Growing Aging Population
  • Increased Focus on Patient Care
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Life Sciences, BY Application (USD Million) | |
      1. 4.1.1 Bone Imaging | |
      2. 4.1.2 Cardiac Imaging | |
      3. 4.1.3 Neuroimaging | |
      4. 4.1.4 Oncology Imaging | |
      5. 4.1.5 Chest Imaging |
    2. 4.2 Life Sciences, BY Modality (USD Million) | |
      1. 4.2.1 X-Ray | |
      2. 4.2.2 CT Scan | |
      3. 4.2.3 MRI | |
      4. 4.2.4 Ultrasound | |
      5. 4.2.5 Nuclear Medicine |
    3. 4.3 Life Sciences, BY End Use (USD Million) | |
      1. 4.3.1 Hospitals | |
      2. 4.3.2 Diagnostic Imaging Centers | |
      3. 4.3.3 Research Organizations | |
      4. 4.3.4 Home Healthcare | |
      5. 4.3.5 Emergency Care |
    4. 4.4 Life Sciences, BY Configuration (USD Million) | |
      1. 4.4.1 Cloud-Based | |
      2. 4.4.2 Web-Based | |
      3. 4.4.3 Standalone 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Life Sciences | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Radiology Partners (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 vRad (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Teleradiology Solutions (IN) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Mednax (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 TeleRadiology (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Nighthawk Radiology (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Global Diagnostics (AU) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 eRAD (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 US MARKET ANALYSIS BY APPLICATION |
    6. 6.3 US MARKET ANALYSIS BY MODALITY |
    7. 6.4 US MARKET ANALYSIS BY END USE |
    8. 6.5 US MARKET ANALYSIS BY CONFIGURATION |
    9. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES |
    10. 6.7 RESEARCH PROCESS OF MRFR |
    11. 6.8 DRO ANALYSIS OF LIFE SCIENCES |
    12. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES |
    13. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES |
    14. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES |
    15. 6.12 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE) |
    16. 6.13 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million) |
    17. 6.14 LIFE SCIENCES, BY MODALITY, 2024 (% SHARE) |
    18. 6.15 LIFE SCIENCES, BY MODALITY, 2024 TO 2035 (USD Million) |
    19. 6.16 LIFE SCIENCES, BY END USE, 2024 (% SHARE) |
    20. 6.17 LIFE SCIENCES, BY END USE, 2024 TO 2035 (USD Million) |
    21. 6.18 LIFE SCIENCES, BY CONFIGURATION, 2024 (% SHARE) |
    22. 6.19 LIFE SCIENCES, BY CONFIGURATION, 2024 TO 2035 (USD Million) |
    23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    24. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    25. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million) | |
      2. 7.2.2 BY MODALITY, 2025-2035 (USD Million) | |
      3. 7.2.3 BY END USE, 2025-2035 (USD Million) | |
      4. 7.2.4 BY CONFIGURATION, 2025-2035 (USD Million) |
    26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.3.1 |
    27. 7.4 ACQUISITION/PARTNERSHIP | |

US Teleradiology Market Segmentation

US Teleradiology Market By Application (USD Million, 2025-2035)

  • Bone Imaging
  • Cardiac Imaging
  • Neuroimaging
  • Oncology Imaging
  • Chest Imaging

US Teleradiology Market By Modality (USD Million, 2025-2035)

  • X-Ray
  • CT Scan
  • MRI
  • Ultrasound
  • Nuclear Medicine

US Teleradiology Market By End Use (USD Million, 2025-2035)

  • Hospitals
  • Diagnostic Imaging Centers
  • Research Organizations
  • Home US Teleradiology Market
  • Emergency Care

US Teleradiology Market By Configuration (USD Million, 2025-2035)

  • Cloud-Based
  • Web-Based
  • Standalone
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.